OLD National Bancorp IN Boosts Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

OLD National Bancorp IN grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 28.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 997 shares of the company’s stock after purchasing an additional 221 shares during the period. OLD National Bancorp IN’s holdings in HCA Healthcare were worth $299,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $39,000. Canoe Financial LP bought a new stake in HCA Healthcare in the 3rd quarter worth approximately $41,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare in the 3rd quarter worth $41,000. Northwest Investment Counselors LLC purchased a new stake in HCA Healthcare during the third quarter valued at $44,000. Finally, Pinnacle Bancorp Inc. grew its stake in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 1.3 %

NYSE HCA opened at $330.24 on Monday. The company has a market capitalization of $83.65 billion, a P/E ratio of 15.03, a P/E/G ratio of 1.12 and a beta of 1.64. The stock has a 50 day moving average price of $313.33 and a 200-day moving average price of $353.29. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the company posted $5.90 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.91 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Insider Transactions at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on HCA shares. Bank of America cut their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.